Inventor
WENT NAOMI
GB15 patents
⚠️ This page may combine multiple inventors who share the name “WENT NAOMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHDI FOUNDATION INC
6 patentsUS9884853B2Feb 6, 2018
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC3 citations72
US9822058B2Nov 21, 2017
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC3 citations71
US9938252B2Apr 10, 2018
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC2 citations70
US10442782B2Oct 15, 2019
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC1 citations61
US10428054B2Oct 1, 2019
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC0 citations51
US10501433B2Dec 10, 2019
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC0 citations49
ENTERPRISE THERAPEUTICS LTD
5 patentsUS12371436B2Jul 29, 2025
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11739094B2Aug 29, 2023
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US10941149B2Mar 9, 2021
Substituted benzodiazoliums as ENaC inhibitors
ENTERPRISE THERAPEUTICS LTD0 citations58
US11370778B2Jun 28, 2022
Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases
ENTERPRISE THERAPEUTICS LTD0 citations48
US10759785B2Sep 1, 2020
Compounds
ENTERPRISE THERAPEUTICS LTD0 citations37
ORCA PHARMACEUTICALS LTD
3 patentsUS10383850B2Aug 20, 2019
Indazole and indole derivatives as inhibitors of retinoic acid related orphan receptor gamma (ROR gamma) for the treatment of immune-related diseases
ORCA PHARMACEUTICALS LTD0 citations45
US9861612B2Jan 9, 2018
Indolyl-containing RORγt inhibitors
ORCA PHARMACEUTICALS LTD0 citations45
US9522134B2Dec 20, 2016
Compounds
ORCA PHARMACEUTICALS LTD0 citations45